Drug Shortage Report for SANDOZ FELODIPINE
Report ID | 161797 |
Drug Identification Number | 02280272 |
Brand name | SANDOZ FELODIPINE |
Common or Proper name | FELODIPINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | FELODIPINE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100PRT BO |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-03 |
Estimated end date | 2022-07-01 |
Actual end date | 2022-06-09 |
Shortage status | Resolved |
Updated date | 2022-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-06-09 | French | Compare |
v4 | 2022-06-09 | English | Compare |
v3 | 2022-06-04 | English | Compare |
v2 | 2022-06-03 | French | Compare |
v1 | 2022-06-03 | English | Compare |
Showing 1 to 5 of 5